All Stories

  1. Anticancer and antimicrobial potential of novel xanthan gum derivatives synthesized via quaternary ammonium grafting
  2. Perspective to Develop Hypoglycemic Nutraceuticals From Polyphenolic Extracts of Apiaceae Using Sustainable Techniques
  3. Xanthan Gum Production and Its Modifications to Obtain Novel Applications: A Review
  4. Cell Differentiation on Hydrogels and its Application in Regenerative Medicine
  5. Antioxidant Activity of Plant Extracts and the Enhance of Their Cytotoxic Effects in Combination with Cisplatin on HeLa Cell Line
  6. Perspectives for Innovation of New Food Preservatives from Euphorbiaceae
  7. The biological applications of IPN hydrogels
  8. Plant Antioxidants: Therapeutic Potential in Cardiovascular Diseases
  9. Drugs targeting APOE4 that regulate beta‐amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease
  10. Development of novel bioactive waterborne polyurethanes: Effect of polyurethane chemical structure on its properties
  11. Collagen‐polyurethane‐dextran hydrogels enhance wound healing by inhibiting inflammation and promoting collagen fibrillogenesis
  12. Corn composition and its health benefits
  13. Polyphenolic characterisation and antiprotozoal effect of extracts obtained by maceration, ultrasound, microwave and ultrasound/microwave of Porophyllum ruderale (Jacq.) Cass.
  14. Fundamental Considerations of Targeted Drug Therapies for Breast Cancer
  15. Horsetail (Equisetum hyemale) Extract Accelerates Wound Healing in Diabetic Rats by Modulating IL-10 and MCP-1 Release and Collagen Synthesis
  16. Nanoencapsulated Systems for Delivery of Phytopharmaceuticals
  17. Determination and comparison of neonatal screening biomarker cutoff points in Mexican newborns against the manufacturerÓ?s cutoff point
  18. Functionality of thermophilic bacteria as probiotics
  19. Antibacterial Potential by Rupture Membrane and Antioxidant Capacity of Purified Phenolic Fractions of Persea americana Leaf Extract
  20. Phenolic compounds of Tagetes lucida Cav. with antibacterial effect due to membrane damage
  21. Security and Biodisponibility of Derivatives from Medicinal Plants in Food Consumption
  22. CARACTERIZACIÓN, DIGESTIBILIDAD Y EFECTO PREBIOTICO DEL EXTRACTO DEL FRUTO DE Stenocereus queretaroensis F.A.C. WEBER BUXBAUM
  23. Applied Techniques for Extraction, Purification, and Characterization of Medicinal Plants Active Compounds
  24. Cardiovascular Responses to 5-hydroxytryptamine in Methimazole-induced Hypothyroid Pithed Rats
  25. Classical and New Pharmaceutical Uses of Bacterial Penicillin G Acylase
  26. Early-life Pb exposure as a potential risk factor for Alzheimer’s disease: are there hazards for the Mexican population?
  27. Cardiovascular Effects Mediated by Imidazoline Drugs: An Update
  28. Chemistry of Medicinal Plants, Foods, and Natural Products and Their Composites
  29. Perspectives for Food Development from Pitayo Stenocereus Queretaroensis (Weber) Buxbaum
  30. Handbook of Research on Food Science and Technology
  31. Carbon nanomaterials as pharmaceutic forms for sustained and controlled delivery systems
  32. CARACTERIZACIÒN PARCIAL DE UNA FRACCIÓN PROTEICA POTENCIALMENTE BIOACTIVA DE Solanum marginatum L. f.
  33. Enzymes in the Pharmaceutical Industry for β-Lactam Antibiotic Production
  34. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α 2 -adrenoceptor subtypes
  35. Extensive preclinical evaluation of an infliximab biosimilar candidate
  36. BIOGUIDED FRACTIONATION FROM Solanum elaeagnifolium TO EVALUATE TOXICITY ON CELLULAR LINES AND BREAST TUMOR EXPLANTS
  37. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats
  38. α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine
  39. Pharmacological characterization of the mechanisms involved in the vasorelaxation induced by progesterone and 17β‐estradiol on isolated canine basilar and carotid arteries
  40. Pharmacological characterization of the mechanisms involved in the vasorelaxation induced by progesterone and 17β-estradiol on isolated canine basilar and internal carotid arteries
  41. Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt
  42. 032 TNF-α and moxonidine interact at the level of MAPKs and Akt in cardiac cells
  43. Pharmacological evidence that Ca2+ channels and, to a lesser extent, K+ channels mediate the relaxation of testosterone in the canine basilar artery
  44. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats
  45. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats
  46. Effect of some acute and prophylactic antimigraine drugs on the vasodepressor sensory CGRPergic outflow in pithed rats
  47. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats
  48. Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats
  49. Pharmacological evidence that α2A- and α2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats